These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

92 related items for PubMed ID: 12862319

  • 1. Cells in G2/M phase increased in human nasopharyngeal carcinoma cell line by EBV-LMP1 through activation of NF-kappaB and AP-1.
    Deng L, Yang J, Zhao XR, Deng XY, Zeng L, Gu HH, Tang M, Cao Y.
    Cell Res; 2003 Jun; 13(3):187-94. PubMed ID: 12862319
    [Abstract] [Full Text] [Related]

  • 2. Upregulated expression of kappa light chain by Epstein-Barr virus encoded latent membrane protein 1 in nasopharyngeal carcinoma cells via NF-kappaB and AP-1 pathways.
    Liu HD, Zheng H, Li M, Hu DS, Tang M, Cao Y.
    Cell Signal; 2007 Feb; 19(2):419-27. PubMed ID: 16979873
    [Abstract] [Full Text] [Related]

  • 3. [Matrix metalloproteinase 9 expression is induced by Epstein-Barr virus LMP1 via NF-kappa B or AP-1 signaling pathway in nasopharyngeal carcinoma cells].
    Wang C, Deng X, Li X, Gu H, Yi W, Weng X, Xia L, Cao Y.
    Zhonghua Zhong Liu Za Zhi; 2002 Jan; 24(1):9-13. PubMed ID: 11977651
    [Abstract] [Full Text] [Related]

  • 4. The transmembrane domains of the EBV-encoded latent membrane protein 1 (LMP1) variant CAO regulate enhanced signalling activity.
    Blake SM, Eliopoulos AG, Dawson CW, Young LS.
    Virology; 2001 Apr 10; 282(2):278-87. PubMed ID: 11289810
    [Abstract] [Full Text] [Related]

  • 5. [Effect of EB virus latent membrane protein 1 on mitosis control of nasopharyngeal carcinoma cell line CNE1].
    Liu B, Chen XY.
    Ai Zheng; 2004 May 10; 23(5):512-6. PubMed ID: 15142445
    [Abstract] [Full Text] [Related]

  • 6. Epstein-Barr virus (EBV) latent membrane protein 1 induces interleukin-8 through the nuclear factor-kappa B signaling pathway in EBV-infected nasopharyngeal carcinoma cell line.
    Ren Q, Sato H, Murono S, Furukawa M, Yoshizaki T.
    Laryngoscope; 2004 May 10; 114(5):855-9. PubMed ID: 15126743
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Decoy receptor 3, upregulated by Epstein-Barr virus latent membrane protein 1, enhances nasopharyngeal carcinoma cell migration and invasion.
    Ho CH, Chen CL, Li WY, Chen CJ.
    Carcinogenesis; 2009 Aug 10; 30(8):1443-51. PubMed ID: 19483191
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The latent membrane protein 1 (LMP1) encoded by Epstein-Barr virus induces expression of the putative oncogene Bcl-3 through activation of the nuclear factor-kappaB.
    Nakamura H, Ishii C, Suehiro M, Iguchi A, Kuroda K, Shimizu K, Shimizu N, Imadome K, Yajima M, Fujiwara S.
    Virus Res; 2008 Feb 10; 131(2):170-9. PubMed ID: 17963943
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Cooperative interactions among p53, bcl-2 and Epstein-Barr virus latent membrane protein 1 in nasopharyngeal carcinoma cells.
    Sheu LF, Chen A, Lee HS, Hsu HY, Yu DS.
    Pathol Int; 2004 Jul 10; 54(7):475-85. PubMed ID: 15189500
    [Abstract] [Full Text] [Related]

  • 14. Lack of cytotoxic property in a variant of Epstein-Barr virus latent membrane protein-1 isolated from nasopharyngeal carcinoma.
    Nitta T, Chiba A, Yamamoto N, Yamaoka S.
    Cell Signal; 2004 Sep 10; 16(9):1071-81. PubMed ID: 15212767
    [Abstract] [Full Text] [Related]

  • 15. Functional analysis of the mutated Epstein-Barr virus oncoprotein LMP1(69del): implications for a new role of naturally occurring LMP1 variants.
    Larcher C, Bernhard D, Schaadt E, Adler B, Ausserlechner MJ, Mitterer M, Huemer HP.
    Haematologica; 2003 Dec 10; 88(12):1324-35. PubMed ID: 14687985
    [Abstract] [Full Text] [Related]

  • 16. [EBV latent membrane protein 1 induces p53 expression via NF-kappa B in nasopharyngeal carcinoma].
    Liao W, Tang M, Yin L.
    Zhonghua Zhong Liu Za Zhi; 2001 May 10; 23(3):199-201. PubMed ID: 11783085
    [Abstract] [Full Text] [Related]

  • 17. Epstein-Barr virus latent membrane protein 1 represses p53-mediated DNA repair and transcriptional activity.
    Liu MT, Chang YT, Chen SC, Chuang YC, Chen YR, Lin CS, Chen JY.
    Oncogene; 2005 Apr 14; 24(16):2635-46. PubMed ID: 15829976
    [Abstract] [Full Text] [Related]

  • 18. Epstein-Barr virus encoded latent membrane protein 1 induces TRAF1 expression to promote anti-apoptosis activity via NF-kappaB signaling pathway in nasopharyngeal carcinoma.
    Wang C, Ai M, Ren W, Xiao H, Li X, Tang F, Gu H, Yi W, Weng X, Deng X, Cao Y.
    Chin Med J (Engl); 2003 Jul 14; 116(7):1022-8. PubMed ID: 12890376
    [Abstract] [Full Text] [Related]

  • 19. Heterodimer formation between c-Jun and Jun B proteins mediated by Epstein-Barr virus encoded latent membrane protein 1.
    Song X, Tao YG, Deng XY, Jin X, Tan YN, Tang M, Wu Q, Lee LM, Cao Y.
    Cell Signal; 2004 Oct 14; 16(10):1153-62. PubMed ID: 15240010
    [Abstract] [Full Text] [Related]

  • 20. Nuclear accumulation of epidermal growth factor receptor and acceleration of G1/S stage by Epstein-Barr-encoded oncoprotein latent membrane protein 1.
    Tao Y, Song X, Deng X, Xie D, Lee LM, Liu Y, Li W, Li L, Deng L, Wu Q, Gong J, Cao Y.
    Exp Cell Res; 2005 Feb 15; 303(2):240-51. PubMed ID: 15652339
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.